Takeda Pharmaceuticals

By Dave Muoio October 25, 2017
A newly announced study backed by Takeda Pharmaceuticals, Lundbeck US, and Advocate Health Care will explore the effectiveness of a mobile app designed to improve engagement between patients with major depressive disorder (MDD) and their providers. The investigation will use the Advocate Pathway App to capture the start of or any adjustments to a patient’s antidepressant therapy. Through a...
By Heather Mack February 27, 2017
Like many cognitive illnesses, clinical depression isn’t a steady state but a variable condition that has patterns and symptoms that change over time and throughout daily life. So Takeda Pharmaceuticals and Cognition Kit are collaborating on a study to assess whether mobile apps and wearables with continuous monitoring capabilities can be used to glean new insights into major depressive disorder...
By Heather Mack November 7, 2016
Pharmaceutical company Takeda is looking to up its digital strategy game, pairing with a few companies to advance clinical trials, analyze data and develop biosensor and wearable technology. Takeda has adopted the platform of Koneska Health, an early stage technology company that works with data gathered through mobile, wearable and other digital technologies to measure health indicators, to...
By Jonah Comstock October 27, 2016
Litmus Health, a company helping pharma companies use wearable devices to improve the efficiency of Phase I and II drug trials, is coming out of public beta and announcing a trial with the University of Chicago testing the effects of activity, sleep, and diet on Inflammatory Bowel Disease (IBD) patients. The trial is funded via a grant from Takeda Pharmaeuticals. "I see so many patients filling...